Follow-The-Filings

Security · featured owners

RGEN Repligen Corp.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 5 Owners
  • Max 2.4%
  • $400M
  • 1 new 3 add

RGEN (Repligen Corp.) is held in 5 featured 13F books as of 2026 Q2. Lee Ainslie - Maverick Capital is the largest tracked holder by portfolio weight (2.4%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 2.4% (Lee Ainslie - Maverick Capital) · not free-float ownership

  1. Lee Ainslie add 2.4%
  2. David Witzke 1.7%
  3. Wallace Weitz add 0.39%
  4. Stanley Druckenmiller new 0.20%
  5. Ron Baron add 0.15%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Lee Ainslie - Maverick Capital 2026 Q2 2.4% Add +30.7% 1,984,554 $271M history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 0.15% Add +36.5% 748,466 $102M history
David Witzke - Avidity Partners Management 2026 Q2 1.7% Hold 77,800 $11M history
Stanley Druckenmiller - Duquesne Family Office 2026 Q2 0.20% New 0.20% 77,400 $11M history
Wallace Weitz - Weitz Investment Management 2026 Q2 0.39% Add +60.0% 40,800 $6M history

5 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 12 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02 Filing Doc
8-K 8.01 Filing Doc
424B3 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.02,7.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Sep 3, 2026 Filing Doc
4 Period Mar 5, 2026 Filing Doc
4 Period Aug 20, 2026 Filing Doc
4 Period Jul 16, 2026 Filing Doc
4 Period Jun 25, 2026 Filing Doc
4 Period May 14, 2026 · 8 forms Filing Doc
4 Period May 7, 2026 · 2 forms Filing Doc
4 Period Apr 21, 2026 Filing Doc
4 Period Mar 5, 2026 · 4 forms Filing Doc
4 Period Mar 4, 2026 · 2 forms Filing Doc
4 Period Mar 2, 2026 Filing Doc
4 Period Feb 27, 2026 · 2 forms Filing Doc

Updated about 2 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $632.36M $634.44M $738.26M
Gross profit * $278.44M $274.64M $386.24M
Gross margin * 44.0% 43.3% 52.3%
Net income $35.6M -$25.51M $48.89M
Net margin * 5.6% -4.0% 6.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.11B $1.07B $1.14B
Total non-current assets $1.72B $1.76B $1.81B
Total assets $2.83B $2.83B $2.95B
Total current liabilities $164.94M $126.79M $135.83M
Total non-current liabilities $701.4M $730.16M $707.74M
Total equity $1.96B $1.97B $2.11B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $113.92M $175.39M $117.42M
Cash from investing -$123.28M -$86.38M -$298.47M
Cash from financing $248.96M -$82.9M -$15.2M
Net change in cash $227.86M $6.03M -$191.33M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders